COVID-19 pandemic
Myanmar receives its first 1.5 million doses of the Oxford-AstraZeneca COVID-19 vaccine manufactured by the Serum Institute of India.
Sources: CNA
Changes
- Myanmar receives the first batch containing 1.5 million doses of Oxford-AstraZeneca COVID-19 vaccine manufactured by the Serum Institute of India to inoculate 750,000 people.
- Myanmar receives its first 1.5 million doses of Oxford-AstraZeneca COVID-19 vaccine manufactured by the Serum Institute of India.
- Myanmar receives its first 1.5 million doses of the Oxford-AstraZeneca COVID-19 vaccine manufactured by the Serum Institute of India.